0

    524414

    NORRIS

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    NORRIS MEDICINES LTD. Share Price Today

    Investment Returns

    Over 1 Month 10.56% Over 3 Months 15.58% Over 6 Months -11.77% Over 1 Year -16.27%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    NORRIS MEDICINES LTD. fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 16.20
    • P/E Ratio (TTM) -52.71
    • Beta 0.20
    • Book Value / share -15.06
    • Return on equity 0.00%
    • EPS (TTM) 0.00
    • Dividend yield [-]%
    • Net profit/quarter (Cr) 0.05
    info icon alternate text

    NORRIS MEDICINES LTD. Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 1.41
    Operating Expense 1.36
    Net Profit 0.05
    Net Profit Margin (%) 3.54
    Earnings Per Share (EPS) 0.05
    EBITDA 0.32
    Effective Tax Rate (%) 0.00
    Particulars DEC 2025 (Values in Cr)
    Revenue 3.27
    Operating Expense 2.57
    Net Profit 0.70
    Net Profit Margin (%) 21.40
    Earnings Per Share (EPS) 0.70
    EBITDA 0.95
    Effective Tax Rate (%) 0.00
    Particulars SEP 2025 (Values in Cr)
    Revenue 2.00
    Operating Expense 2.71
    Net Profit -0.72
    Net Profit Margin (%) -36.00
    Earnings Per Share (EPS) -0.72
    EBITDA -0.49
    Effective Tax Rate (%) 0.00
    Particulars JUN 2025 (Values in Cr)
    Revenue 1.46
    Operating Expense 1.79
    Net Profit -0.31
    Net Profit Margin (%) -21.23
    Earnings Per Share (EPS) -0.31
    EBITDA -0.08
    Effective Tax Rate (%) 0.00
    Particulars MAR 2025 (Values in Cr)
    Revenue 2.72
    Operating Expense 2.94
    Net Profit -0.23
    Net Profit Margin (%) -8.45
    Earnings Per Share (EPS) -0.23
    EBITDA 0.12
    Effective Tax Rate (%) -35.29
    Particulars MAR 2026 (Values in Cr)
    Revenue 8.13
    Operating Expense 8.46
    Net Profit -0.28
    Net Profit Margin (%) -3.44
    Earnings Per Share (EPS) -0.28
    EBITDA 0.71
    Effective Tax Rate (%) 0.00
    Particulars MAR 2025 (Values in Cr)
    Revenue 5.82
    Operating Expense 7.06
    Net Profit -1.24
    Net Profit Margin (%) -21.30
    Earnings Per Share (EPS) -1.24
    EBITDA -0.19
    Effective Tax Rate (%) -5.08
    Particulars MAR 2024 (Values in Cr)
    Revenue 5.64
    Operating Expense 6.76
    Net Profit -1.19
    Net Profit Margin (%) -21.09
    Earnings Per Share (EPS) -1.19
    EBITDA -0.16
    Effective Tax Rate (%) -8.18
    Particulars MAR 2023 (Values in Cr)
    Revenue 8.36
    Operating Expense 9.57
    Net Profit -1.75
    Net Profit Margin (%) -20.93
    Earnings Per Share (EPS) -1.75
    EBITDA 0.94
    Effective Tax Rate (%) -47.05
    Particulars MAR 2022 (Values in Cr)
    Revenue 9.44
    Operating Expense 11.65
    Net Profit -3.26
    Net Profit Margin (%) -34.53
    Earnings Per Share (EPS) -3.26
    EBITDA -0.04
    Effective Tax Rate (%) -49.54
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share -14.98
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.00
    EBITDA Margin -3.44
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share -13.73
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.00
    EBITDA Margin -2.84
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share -12.54
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.00
    EBITDA Margin 11.24
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share -10.77
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.00
    EBITDA Margin -0.53
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share -7.49
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.00
    EBITDA Margin -13.88
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 0.03
    Total Assets 13.80
    Total Liabilities 13.80
    Total Equity -14.86
    Share Outstanding 0
    Price to Book Ratio -1.12
    Return on Assets (%) -8.96
    Return on Capital (%) -18.43
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 0.03
    Total Assets 14.18
    Total Liabilities 14.18
    Total Equity -13.63
    Share Outstanding 0
    Price to Book Ratio -0.99
    Return on Assets (%) -8.36
    Return on Capital (%) -15.03
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 0.02
    Total Assets 13.68
    Total Liabilities 13.68
    Total Equity -12.44
    Share Outstanding 0
    Price to Book Ratio -0.83
    Return on Assets (%) -12.78
    Return on Capital (%) -19.52
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 0.01
    Total Assets 14.19
    Total Liabilities 14.19
    Total Equity -10.69
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) -22.99
    Return on Capital (%) -31.43
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 0.02
    Total Assets 19.78
    Total Liabilities 19.78
    Total Equity -7.43
    Share Outstanding 0
    Price to Book Ratio -0.87
    Return on Assets (%) -25.07
    Return on Capital (%) -61.31
    Particulars MAR 2025 (Values in Cr)
    Net Income -1.23
    Cash from Operations 0.51
    Cash from Investing 0.00
    Cash from Financing -0.50
    Net change in Cash 0.00
    Free Cash Flow 0.52
    Particulars MAR 2024 (Values in Cr)
    Net Income -1.18
    Cash from Operations 0.16
    Cash from Investing 0.05
    Cash from Financing -0.20
    Net change in Cash 0.01
    Free Cash Flow 0.17
    Particulars MAR 2023 (Values in Cr)
    Net Income -1.74
    Cash from Operations 1.19
    Cash from Investing -0.02
    Cash from Financing -1.17
    Net change in Cash 0.00
    Free Cash Flow 1.22
    Particulars MAR 2022 (Values in Cr)
    Net Income -3.26
    Cash from Operations -1.00
    Cash from Investing -0.08
    Cash from Financing 1.09
    Net change in Cash 0.00
    Free Cash Flow -0.95
    Particulars MAR 2021 (Values in Cr)
    Net Income -4.96
    Cash from Operations 1.11
    Cash from Investing -0.06
    Cash from Financing -1.09
    Net change in Cash -0.04
    Free Cash Flow 1.20
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 32.72 13.52 1.58 250.74 23.12 38.85
    BLISS GVS PHARMA LTD 506.15 40.69 4.49 5368.04 118.35 552.90
    CIPLA LTD 1458.45 30.95 3.42 117820.20 1165.55 1672.20
    FERMENTA BIOTECH LTD. 345.85 15.26 2.50 1017.87 256.40 399.00
    GLAXOSMITHKLINE PHARMA LT 2392.75 42.13 17.87 40534.63 2088.00 3362.55
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 32.72 22.88 4.21 250.74 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 536.85 24.06 4.19 1552.07 490.00 789.95
    ASTRAZENECA PHARMA IND LT 8297.90 108.37 23.76 20744.75 7630.00 9850.00
    BLISS GVS PHARMA LTD 506.15 54.72 4.64 5368.04 118.35 552.90

    NORRIS MEDICINES LTD. shareholding pattern

    Holding
    65.91%
    34.01%
    0.06%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    NORRIS MEDICINES LTD. Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    16.23 9.95 redarrow
    red-green-graph indicator
    0 Bearish
    16 Bullish
    • 5 Days 14.40
    • 26 Days 13.90
    • 10 Days 14.20
    • 50 Days 13.90
    • 12 Days 14.10
    • 100 Days 14.10
    • 20 Days 14.00
    • 200 Days 14.80
    14.67 PIVOT
    First Support 14.34 First Resistance 15.09 Second Support 13.92 Second Resistance 15.42 Third Support 13.59 Third Resistance 15.84
    RSI 56.95 ADX 33.27 MACD 0.18 Williams % R -21.78 Commodity Channel Index (CCI) 167.95
    Date 2026-07-03 Week 2713.00 Same Day 131.00 Month 1947.00
    1 Year 0.20 3 Year 0.25
    Over 1 Month
    10.56% down
    Over 1 Year
    -16.27% down
    Over 3 Months
    15.58% down
    Over 3 Years
    9.99% down
    Over 6 Months
    -11.77% down
    Over 5 Years
    20.74% down

    NORRIS MEDICINES LTD. Corporate Actions

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Norris Medicines Ltd?

    Answer Field

    Norris Medicines Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 16.23 as on Jul 06 2026 01:18 PM.

    What is the Market Cap of Norris Medicines Ltd Share?

    Answer Field

    The market cap of Norris Medicines Ltd for NSE ₹ 0.00 & for BSE ₹ 16.20 as on Jul 06 2026 01:18 PM.

    What is the 52 Week High and Low of Norris Medicines Ltd?

    Answer Field

    The 52 Week High and Low of Norris Medicines Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 19.25 and ₹ 12.00.

    What is 1 year return for Norris Medicines Ltd?

    Answer Field

    The 1 year returns on the stock has been -16.27%.

    What is the P/E Ratio of Norris Medicines Ltd Share?

    Answer Field

    As on Jul 06 2026 01:18 PM the price-to-earnings (PE) ratio for Norris Medicines Ltd share is -52.71.

    What is the PB ratio of Norris Medicines Ltd Share?

    Answer Field

    As on Jul 06 2026 01:18 PM, the price-to-book (PB) ratio for Norris Medicines Ltd share is -15.06.

    How to Buy Norris Medicines Ltd Share?

    Answer Field

    You can trade in Norris Medicines Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Norris Medicines Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Norris Medicines Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Norris Medicines Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |